References
- Abouelatta SM, Aboelwafa AA, Khalil RM, Elgazayerly ON. (2015). Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: in-vitro optimization and in-vivo performance in humans. Eur J Pharm Biopharm 89:82–92
- Arora S, Ali J, Ahuja A, et al. (2005). Floating drug delivery systems: a review. AAPS PharmSciTech 6:E372–90
- Badve SS, Sher P, Korde A, Pawar AP. (2007). Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm Biopharm 65:85–93
- Basalious EB, Shawky N, Badr-Eldin SM. (2010). Snedds containing bioenhancers for improvement of dissolution and oral absorption of lacidipine: I. Development and optimization. Int J Pharm 391:203–11
- El-Kamel AH, Al-Gohary OM, Hosny EA. (2003). Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability. J Microencapsul 20:211–25
- Fernandez S, Chevrier S, Ritter N, et al. (2009). In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients labrasol and gelucire 44/14. Pharm Res 26:1901–10
- Furlanetto S, Cirri M, Maestrelli F, et al. (2006). Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Eur J Pharm Biopharm 62:77–84
- Huang YB, Tsai YH, Yang WC, et al. (2004). Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm 58:607–14
- Jain SK, Gupta A. (2009). Development of gelucire 43/01 beads of metformin hydrochloride for floating delivery. AAPS PharmSciTech 10:1128–36
- Kumar MK, Shah MH, Ketkar A, et al. (2004). Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int J Pharm 272:151–60
- Lewis GA, Mathieu D, Phan RTL. (1999). Pharmaceutical experimental design. New York: Dekker
- Masaoka Y, Tanaka Y, Kataoka M, et al. (2006). Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. Eur J Pharm Sci 29:240–50
- Mura P, Furlanetto S, Cirri M, et al. (2005). Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and d-optimal mixture experimental design. J Pharm Biomed Anal 37:65–71
- Patel D, Dasgupta S, Dey S, et al. (2012). Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm 80:749
- Pawar AP, Gadhe AR, Venkatachalam P, et al. (2008). Effect of core and surface cross-linking on the entrapment of metronidazole in pectin beads. Acta Pharm 58:78–85
- Roy P, Shahiwala A. (2009). Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release 134:74–80
- Shidhaye SS. (2009). Sustained release floating drug delivery system of in-situ gelling suspension of cinnarizine. J Pharm Res 2:449
- Sriamornsak P, Asavapichayont P, Nunthanid J, et al. (2008). Wax-incorporated emulsion gel beads of calcium pectinate for intragastric floating drug delivery. AAPS PharmSciTech 9:571–6
- Sriamornsak P, Nunthanid J. (1999). Calcium pectinate gel beads for controlled release drug delivery: II. Effect of formulation and processing variables on drug release. J Microencapsul 16:303–13
- Sriamornsak P, Thirawong N, Puttipipatkhachorn S. (2004). Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS PharmSciTech 6:E24
- Streubel A, Siepmann J, Bodmeier R. (2006). Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 6:501–8
- Wang S, Sun M, Ping Q. (2008). Enhancing effect of Labrafac Lipophile wl 1349 on oral bioavailability of hydroxysafflor yellow a in rats. Int J Pharm 358:198–204